Stay updated on Adjunctive Troriluzule in OCD Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.

Latest updates to the Adjunctive Troriluzule in OCD Clinical Trial page
- Check2 days agoChange DetectedThe record history now reflects a new revision, v3.6.4, replacing v3.6.3, indicating a minor update to the page's version. This change is contextual to the page's rendering/metadata rather than the study information.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe footer revision tag updated from v3.6.2 to v3.6.3, indicating a newer page version.SummaryDifference0.0%

- Check31 days agoChange DetectedThe record history now shows Revision: v3.6.2, replacing Revision: v3.6.0. This indicates a newer release was applied to the page’s history, reflecting an update to the site’s versioning rather than changes to the study data.SummaryDifference0.0%

- Check45 days agoChange DetectedRecruitment for the study has ended. The record version has been updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

- Check52 days agoChange DetectedThe UI now displays Revision: v3.5.5, replacing v3.5.4 on the page. This reflects a small platform update to the record history view.SummaryDifference0.0%

- Check59 days agoChange DetectedThe study title was corrected to 'A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder', and the history log was updated to reflect the latest version with added sections such as Results Posted, Baseline Characteristics, Participant Flow, Document Section, IPDSharing, Eligibility, and Study Identification.SummaryDifference0.7%

Stay in the know with updates to Adjunctive Troriluzule in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.